ATC
NVO

Argent Trust Co’s Novo Nordisk NVO Stock Holding History

Argent Trust Co’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$956K Buy
19,937
+6,109
+44% +$262K 0.03% 367
2026
Q1 		$508K Buy
13,828
+3,171
+30% +$150K 0.02% 467
2025
Q4 		$542K Buy
10,657
+683
+7% +$34.9K 0.02% 448
2025
Q3 		$553K Sell
9,974
-833
-8% -$48.8K 0.02% 442
2025
Q2 		$746K Buy
10,807
+648
+6% +$44.1K 0.03% 374
2025
Q1 		$705K Buy
10,159
+1,919
+23% +$158K 0.03% 373
2024
Q4 		$709K Sell
8,240
-1,512
-16% -$164K 0.03% 368
2024
Q3 		$1.16M Buy
9,752
+794
+9% +$106K 0.05% 290
2024
Q2 		$1.28M Buy
8,958
+1,824
+26% +$242K 0.06% 271
2024
Q1 		$916K Sell
7,134
-134
-2% -$16K 0.04% 322
2023
Q4 		$752K Sell
7,268
-334
-4% -$33K 0.04% 335
2023
Q3 		$691K Sell
7,602
-414
-5% -$36.5K 0.04% 335
2023
Q2 		$649K Hold
8,016
– – 0.04% 357
2023
Q1 		$638K Sell
8,016
-2,050
-20% -$145K 0.04% 322
2022
Q4 		$681K Hold
10,066
– – 0.05% 300
2022
Q3 		$502K Sell
10,066
-10
-0.1% -$536 0.04% 335
2022
Q2 		$562K Buy
10,076
+142
+1% +$7.88K 0.04% 325
2022
Q1 		$552K Hold
9,934
– – 0.03% 337
2021
Q4 		$556K Hold
9,934
– – 0.03% 342
2021
Q3 		$477K Buy
9,934
+128
+1% +$6.19K 0.03% 355
2021
Q2 		$411K Buy
9,806
+746
+8% +$28.9K 0.03% 380
2021
Q1 		$305K Sell
9,060
-236
-3% -$8.41K 0.02% 418
2020
Q4 		$325K Buy
+9,296
New +$321K 0.03% 382

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Argent Trust Co's NVO Position: Q2 2026 in Review

Argent Trust Co increased its Novo Nordisk (NVO) stake by 44% in Q2 2026, buying an estimated $262K and bringing the position to 19,937 shares worth $956K. The position accounts for 0.03% of the portfolio, ranked #367.

Argent Trust Co first reported a position in NVO in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.28M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Argent Trust Co held 19,937 shares of Novo Nordisk worth $956K as of Q2 2026.
  • Argent Trust Co bought 6,109 Novo Nordisk shares in Q2 2026, an estimated $262K.
  • Novo Nordisk made up 0.03% of Argent Trust Co's portfolio in Q2 2026, its #367 holding.
  • Argent Trust Co first reported a position in Novo Nordisk in Q4 2020 and has held it in 23 quarters since.
  • Argent Trust Co's Novo Nordisk position peaked at $1.28M in Q2 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Argent Trust Co's 13F filing for Q2 2026, filed 6 Aug 2026.